Gain-of-function mutations within NLRP3 are associated with the autoinflammatory disease cryopyrin-associated periodic syndrome (CAPS), and aberrant or excessive activation of NLRP3 has been linked to pathogenesis in SLE and various forms of arthritis (142, 144, 145). This evidence concerns the gene NLRP3 and systemic lupus erythematosus.